30
Participants
Start Date
June 28, 2023
Primary Completion Date
August 12, 2025
Study Completion Date
June 1, 2026
Compound 21
"AT2R sensitivity: compound 21, and compound 21+ L-NAME (nitric oxide synthase inhibitor) are locally and acutely delivered to the cutaneous microvasculature to assess AT2R-mediated dilation and role of nitric oxide in this response~Local heating: compound 21 is locally and acutely delivered to the cutaneous microvasculature during local heating of the skin to assess endothelium-dependent dilation, L-NAME is added to assess nitric oxide-dependent dilation during this response"
RECRUITING
University of Iowa, Iowa City
Anna Stanhewicz, PhD
OTHER